~Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation~
Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware’s deep domain expertise and Abluva’s groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment—without hindering innovation.
Partnership Highlights:s
- Real-time Agent Governance: Abluva’s Secure Intelligence Plane enforces critical controls like purpose binding, role-based context augmentation, data masking, and tooling control to prevent unauthorized actions.
- Comprehensive Agent Life Cycle Security: Security protocols to protect sensitive data span the entire Agent life cycle, including fine-tuning, Retrieval Augmented Generation (RAG), and prompting stages. This provides advanced visibility and targeted safeguards specifically designed for agent-driven architectures in clinical and research settings.
- Autonomous Threat Mitigation and Self-Healing: Abluva’s patent-pending “self-healing” capability allows the system to automatically detect and respond to unforeseen or anomalous agent behaviors in real-time, reducing risks associated with agent autonomy.
- Enhanced Compliance and Privacy for AI: The solution ensures agent activities comply with industry standards like HIPAA and GDPR, and internal governance policies, through embedded governance and audit features, addressing crucial aspects of data privacy.
“We are thrilled to partner with Abluva to implement the most secure agentic AI solutions for large sponsors and CROs,” said, Raj Gondhali, AVP & Head of Clinical Solutions, Hexaware. “This collaboration is pivotal, combining our expertise in global clinical solutions with Abluva’s pioneering agentic security technology to ensure enhanced AI safety, compliance, and operational efficiency as our clients adopt next-generation AI.”
Raj Darji, CEO at Abluva, echoed similar sentiments: “We are excited to announce our partnership with Hexaware, a global systems integration specialist renowned for its Life Sciences expertise. This collaboration marks a significant milestone for Abluva as we aim to deliver value and innovative solutions in agentic AI security. By combining Hexaware’s global reach with our novel research-based technology for securing autonomous agents, we are committed to providing comprehensive and integrated solutions that enable safe AI adoption.”
Amit Gautam, CTO at Abluva, added, “Our partnership with Hexaware enables us to extend our expertise in agentic AI security to a broader market, addressing the critical need for robust governance in AI-driven enterprises. By integrating our Secure Intelligence Plane with Hexaware’s capabilities, we can deliver sophisticated, real-time governance solutions tailored to secure autonomous AI agents in complex life sciences environments.” This partnership underlines Hexaware’s commitment to next-generation cloud and AI platforms, and Abluva’s leadership in research-driven, agentic security innovations. Together, they empower life sciences enterprises to unlock GenAI’s full potential—securely, at scale.
